Rhumbline Advisers Reduces Position in Healthpeak Properties, Inc. $DOC

Rhumbline Advisers decreased its position in Healthpeak Properties, Inc. (NYSE:DOC) by 4.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 1,395,093 shares of the real estate investment trust’s stock after selling 62,318 shares during the period. Rhumbline Advisers owned about 0.20% of Healthpeak Properties worth $26,716,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DOC. Integrated Wealth Concepts LLC grew its holdings in Healthpeak Properties by 7.3% in the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock worth $366,000 after acquiring an additional 1,231 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Healthpeak Properties by 110.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock worth $2,463,000 after purchasing an additional 63,930 shares during the last quarter. Woodline Partners LP increased its holdings in Healthpeak Properties by 41.3% during the 1st quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock valued at $1,195,000 after purchasing an additional 17,279 shares during the period. Apollon Wealth Management LLC bought a new position in Healthpeak Properties during the 2nd quarter valued at approximately $181,000. Finally, Concurrent Investment Advisors LLC raised its position in Healthpeak Properties by 148.5% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 27,879 shares of the real estate investment trust’s stock valued at $488,000 after purchasing an additional 16,661 shares during the last quarter. 93.57% of the stock is currently owned by institutional investors.

Healthpeak Properties Price Performance

DOC opened at $16.70 on Monday. The company has a current ratio of 2.82, a quick ratio of 2.82 and a debt-to-equity ratio of 1.21. The company has a market cap of $11.60 billion, a price-to-earnings ratio of 166.97, a price-to-earnings-growth ratio of 8.96 and a beta of 1.12. The stock has a fifty day simple moving average of $16.79 and a two-hundred day simple moving average of $17.55. Healthpeak Properties, Inc. has a 12-month low of $15.71 and a 12-month high of $21.28.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, topping analysts’ consensus estimates of $0.45 by $0.02. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The firm had revenue of $719.40 million for the quarter, compared to the consensus estimate of $685.14 million. During the same period in the prior year, the firm earned $0.46 EPS. The company’s revenue was up 3.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Research analysts predict that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The business also recently declared a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a dividend of $0.1017 per share. The ex-dividend date is Tuesday, March 17th. This represents a c) annualized dividend and a dividend yield of 7.3%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 1,220.00%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Wells Fargo & Company reissued a “positive” rating on shares of Healthpeak Properties in a research note on Tuesday, February 3rd. Jefferies Financial Group cut shares of Healthpeak Properties from a “buy” rating to a “hold” rating and cut their price target for the company from $21.00 to $17.00 in a report on Monday, December 15th. Robert W. Baird decreased their price objective on shares of Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating for the company in a report on Wednesday, November 12th. Cantor Fitzgerald set a $17.00 target price on shares of Healthpeak Properties in a research report on Monday, January 5th. Finally, The Goldman Sachs Group assumed coverage on shares of Healthpeak Properties in a research note on Friday, January 9th. They set a “neutral” rating and a $17.00 target price on the stock. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $19.42.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.